Potravitug

波查韦塔单抗

Report date: 2025/11/11 17:42:45

Base Information

Drug NamePotravitug
Drug Alias NameAntiBKV neutralising antibodyAntiBKVMTX-005
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsBK Polyomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMemo Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesMemo Therapeutics AG
Inactive CompaniesN/A
Active IndicationsBK Polyomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A